These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9076751)

  • 21. Pharmacological characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action.
    Schoepp DD; Ornstein PL; Leander JD; Lodge D; Salhoff CR; Zeman S; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1301-8. PubMed ID: 2148188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid derivatives with anticonvulsant activity.
    Paruszewski R; Strupińska M; Stables JP; Swiader M; Czuczwar S; Kleinrok Z; Turski W
    Chem Pharm Bull (Tokyo); 2001 May; 49(5):629-31. PubMed ID: 11383620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticonvulsant activities of 1-phenylcyclohexylamine and its conformationally restricted analog 1,1-pentamethylenetetrahydroisoquinoline.
    Rogawski MA; Thurkauf A; Yamaguchi S; Rice KC; Jacobson AE; Mattson MV
    J Pharmacol Exp Ther; 1989 Jun; 249(3):708-12. PubMed ID: 2659775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drug.
    Isoherranen N; White HS; Finnell RH; Yagen B; Woodhead JH; Bennett GD; Wilcox KS; Barton ME; Bialer M
    Epilepsia; 2002 Feb; 43(2):115-26. PubMed ID: 11903457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity.
    Giardina WJ; Dart MJ; Harris RR; Bitner RS; Radek RJ; Fox GB; Chemburkar SR; Marsh KC; Waring JF; Hui JY; Chen J; Curzon P; Grayson GK; Komater VA; Ku Y; Lockwood M; Miner HM; Nikkel AL; Pan JB; Pu YM; Wang L; Bennani Y; Durmuller N; Jolly R; Roux S; Sullivan JP; Decker MW
    Epilepsia; 2005 Sep; 46(9):1349-61. PubMed ID: 16146429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.
    Geurts M; Poupaert JH; Scriba GK; Lambert DM
    J Med Chem; 1998 Jan; 41(1):24-30. PubMed ID: 9438018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of N-methyl-D-aspartate (NMDA)-induced kindling.
    Croucher MJ; Cotterell KL; Bradford HF
    Biochem Soc Trans; 1996 May; 24(2):295S. PubMed ID: 8736953
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of some 2-substituted derivatives of xanthone for anticonvulsant properties.
    Marona H
    Pharmazie; 1998 Jun; 53(6):405-9. PubMed ID: 9675771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [COMPARISON OF CHRONIC ANTICONVULSANT ACTIVITY AND SAFETY OF IEM-2062, SODIUM VALPROATE AND ME-MANTINE IN THE PENTYLENETETRAZOL KINDLING MODEL IN RATS].
    Gmiro VE; Serdyuk SE; Veselkina OS
    Ross Fiziol Zh Im I M Sechenova; 2017 Mar; 103(3):299-306. PubMed ID: 30199210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
    Gavzan H; Sayyah M; Sardari S; Babapour V
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1029-38. PubMed ID: 26018398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New derivatives of benzylamide with anticonvulsant activity.
    Strupińska M; Rostafińska-Suchar G; Stables JP; Paruszewski R
    Acta Pol Pharm; 2009; 66(2):155-9. PubMed ID: 19719049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Biological Activity, and Docking Study of Novel Isatin Coupled Thiazolidin-4-one Derivatives as Anticonvulsants.
    Nikalje AP; Ansari A; Bari S; Ugale V
    Arch Pharm (Weinheim); 2015 Jun; 348(6):433-45. PubMed ID: 25903766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.
    Matagne A; Klitgaard H
    Epilepsy Res; 1998 Jun; 31(1):59-71. PubMed ID: 9696301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
    Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
    Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
    Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T
    J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
    Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH
    Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.